McMaster team closes in on cause of rare blood clots related to AstraZeneca COVID-19 vaccine
"Canadian researchers have established the most definitive link yet between the Oxford-AstraZeneca COVID-19 vaccine and a rare blood clotting syndrome that shattered public confidence in the vaccine earlier this year.
The work, conducted by a team at McMaster University, has yielded a more efficient way to test for the syndrome and also lays out the underlying mechanism that is producing blood clots in a small fraction of vaccinated individuals."
- By Ivan Semeniuk, Science Reporter, The Globe and Mail